{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:09:49Z","timestamp":1790726989246,"version":"4.1.0"},"reference-count":160,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"am","delay-in-days":310,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005851","name":"Shahid Beheshti University of Medical Sciences","doi-asserted-by":"publisher","award":["43016704-4"],"award-info":[{"award-number":["43016704-4"]}],"id":[{"id":"10.13039\/501100005851","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["2U54MD017979-01A1"],"award-info":[{"award-number":["2U54MD017979-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nitric Oxide"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.niox.2025.10.001","type":"journal-article","created":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T23:16:12Z","timestamp":1759706172000},"page":"89-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Diabetic nephropathy: Role of nitric oxide"],"prefix":"10.1016","volume":"159","author":[{"given":"Sajad","family":"Jeddi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4060-7283","authenticated-orcid":false,"given":"Khosrow","family":"Kashfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asghar","family":"Ghasemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.niox.2025.10.001_bib1","series-title":"IDF Diabetes Atlas, 11th Ed","author":"Diabetes Federation","year":"2025"},{"key":"10.1016\/j.niox.2025.10.001_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115734","article-title":"Diabetes mellitus: classification, mediators, and complications; A gate to identify potential targets for the development of new effective treatments","volume":"168","author":"Antar","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"6","key":"10.1016\/j.niox.2025.10.001_bib3","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1001\/jama.2016.10924","article-title":"Clinical manifestations of kidney disease among US adults with diabetes, 1988-2014","volume":"316","author":"Afkarian","year":"2016","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.niox.2025.10.001_bib4","first-page":"229","article-title":"Diabetic neuropathy prevalence and its associated risk factors in two representative groups of type 1 and type 2 diabetes mellitus patients from Bihor county","volume":"13","author":"Andrei","year":"2018","journal-title":"Maedica"},{"issue":"1","key":"10.1016\/j.niox.2025.10.001_bib5","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/jdi.12244","article-title":"Nitric oxide donors rescue diabetic nephropathy through oxidative-stress-and nitrosative-stress-mediated Wnt signaling pathways","volume":"6","author":"Hsu","year":"2015","journal-title":"J. Diabetes Investig."},{"issue":"2 Suppl 1","key":"10.1016\/j.niox.2025.10.001_bib6","first-page":"S38","volume":"32","year":"1998","journal-title":"Am. J. Kidney Dis. : off. J. National Kidney Found."},{"key":"10.1016\/j.niox.2025.10.001_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.672350","article-title":"Global, regional, and national burden of diabetes-related chronic kidney disease from 1990 to 2019","volume":"12","author":"Deng","year":"2021","journal-title":"Front. Endocrinol."},{"issue":"1","key":"10.1016\/j.niox.2025.10.001_bib8","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.mpmed.2014.10.007","article-title":"Diabetic nephropathy","volume":"43","author":"Thomas","year":"2015","journal-title":"Medicine"},{"issue":"3","key":"10.1016\/j.niox.2025.10.001_bib9","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3390\/kidneydial2030038","article-title":"The epidemiology of diabetic kidney disease","volume":"2","author":"Hoogeveen","year":"2022","journal-title":"Kidney and Dialysis"},{"issue":"9","key":"10.1016\/j.niox.2025.10.001_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2024.100873","article-title":"Healthcare costs across diabetic kidney disease stages: a veterans affairs study","volume":"6","author":"Kim","year":"2024","journal-title":"Kidney Med."},{"issue":"12","key":"10.1016\/j.niox.2025.10.001_bib11","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.2337\/dci22-0027","article-title":"Diabetes management in chronic kidney disease: a consensus report by the American diabetes association (ADA) and kidney disease: improving global outcomes (KDIGO)","volume":"45","author":"de Boer","year":"2022","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.niox.2025.10.001_bib12","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1681\/ASN.2010010010","article-title":"Pathologic classification of diabetic nephropathy","volume":"21","author":"Tervaert","year":"2010","journal-title":"J. Am. Soc. Nephrol. : JASN"},{"issue":"2","key":"10.1016\/j.niox.2025.10.001_bib13","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/jdi.12319","article-title":"A new classification of diabetic nephropathy 2014: a report from joint committee on diabetic nephropathy","volume":"6","author":"Haneda","year":"2015","journal-title":"J. Diabetes Investig."},{"issue":"2 Suppl 1","key":"10.1016\/j.niox.2025.10.001_bib14","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","author":"Foundation","year":"2002","journal-title":"Am. J. Kidney Dis. : off. J. National Kidney Found."},{"issue":"4s","key":"10.1016\/j.niox.2025.10.001_bib15","first-page":"S117","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","year":"2024","journal-title":"Kidney Int."},{"issue":"Suppl 2","key":"10.1016\/j.niox.2025.10.001_bib16","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.2337\/diab.46.2.S104","article-title":"How to protect the kidney in diabetic patients: with special reference to IDDM","volume":"46","author":"Mogensen","year":"1997","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.niox.2025.10.001_bib17","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41581-021-00429-z","article-title":"Nitric oxide signalling in kidney regulation and cardiometabolic health","volume":"17","author":"Carlstr\u00f6m","year":"2021","journal-title":"Nat. Rev. Nephrol."},{"issue":"1","key":"10.1016\/j.niox.2025.10.001_bib18","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1046\/j.1523-1755.2003.00078.x","article-title":"Expression of NOS1 and soluble guanylyl cyclase by human kidney epithelial cells: morphological evidence for an autocrine\/paracrine action of nitric oxide","volume":"64","author":"Jarry","year":"2003","journal-title":"Kidney Int."},{"issue":"5 Pt 2","key":"10.1016\/j.niox.2025.10.001_bib19","first-page":"F748","article-title":"In situ hybridization localization of mRNA encoding inducible nitric oxide synthase in rat kidney","volume":"267","author":"Ahn","year":"1994","journal-title":"Am. J. Physiol."},{"issue":"3","key":"10.1016\/j.niox.2025.10.001_bib20","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.kint.2021.10.037","article-title":"Role of the macula densa sodium glucose cotransporter type 1-neuronal nitric oxide synthase-tubuloglomerular feedback pathway in diabetic hyperfiltration","volume":"101","author":"Zhang","year":"2022","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.niox.2025.10.001_bib21","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3349\/ymj.2002.43.2.183","article-title":"Inducible nitric oxide synthase (iNOS) expression is increased in lipopolysaccharide (LPS)-Stimulated diabetic rat glomeruli: effect of ACE inhibitor and angiotensin II receptor blocker","volume":"43","author":"Lee","year":"2002","journal-title":"Yonsei Med. J."},{"issue":"11","key":"10.1016\/j.niox.2025.10.001_bib22","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1681\/ASN.2011121170","article-title":"eNOS deficiency predisposes podocytes to injury in diabetes","volume":"23","author":"Yuen","year":"2012","journal-title":"J. Am. Soc. Nephrol. : JASN"},{"issue":"5","key":"10.1016\/j.niox.2025.10.001_bib23","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.2353\/ajpath.2007.060481","article-title":"Deficiency of endothelial nitric-oxide synthase confers susceptibility to diabetic nephropathy in nephropathy-resistant inbred mice","volume":"170","author":"Kanetsuna","year":"2007","journal-title":"Am. J. Pathol."},{"issue":"7","key":"10.1016\/j.niox.2025.10.001_bib24","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1007\/s001250051241","article-title":"Advanced glycation end products-cytokine-nitric oxide sequence pathway in the development of diabetic nephropathy: aminoguanidine ameliorates the overexpression of tumour necrosis factor-alpha and inducible nitric oxide synthase in diabetic rat glomeruli","volume":"42","author":"Sugimoto","year":"1999","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.niox.2025.10.001_bib25","doi-asserted-by":"crossref","first-page":"F1121","DOI":"10.1152\/ajprenal.00265.2002","article-title":"Paradoxes of nitric oxide in the diabetic kidney","volume":"284","author":"Komers","year":"2003","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"2","key":"10.1016\/j.niox.2025.10.001_bib26","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.niox.2004.08.005","article-title":"Effects of long-term inhibition of neuronal nitric oxide synthase (NOS1) in uninephrectomized diabetic rats","volume":"11","author":"Komers","year":"2004","journal-title":"Nitric Oxide : Biol. Chem."},{"issue":"2","key":"10.1016\/j.niox.2025.10.001_bib27","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1067\/mlc.2001.112691","article-title":"An analysis of renal nitric oxide contribution to hyperfiltration in diabetic rats","volume":"137","author":"Schwartz","year":"2001","journal-title":"J. Lab. Clin. Med."},{"issue":"3","key":"10.1016\/j.niox.2025.10.001_bib28","doi-asserted-by":"crossref","first-page":"F573","DOI":"10.1152\/ajprenal.2000.279.3.F573","article-title":"Role of neuronal nitric oxide synthase (NOS1) in the pathogenesis of renal hemodynamic changes in diabetes","volume":"279","author":"Komers","year":"2000","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"6","key":"10.1016\/j.niox.2025.10.001_bib29","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1161\/HYPERTENSIONAHA.121.17643","article-title":"Knockout of macula densa neuronal nitric oxide synthase increases blood pressure in Db\/Db mice","volume":"78","author":"Zhang","year":"2021","journal-title":"Hypertension (Dallas, Tex : 1979)"},{"issue":"5","key":"10.1016\/j.niox.2025.10.001_bib30","doi-asserted-by":"crossref","first-page":"F889","DOI":"10.1152\/ajprenal.00023.2019","article-title":"Comparison of diabetic nephropathy between Male and female eNOS(-\/-)db\/db mice","volume":"316","author":"Ma","year":"2019","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"7","key":"10.1016\/j.niox.2025.10.001_bib31","first-page":"12","article-title":"The effect of selected nitric oxide synthase polymorphisms on the risk of developing diabetic nephropathy","volume":"13","author":"Kr\u00f3l-Kulikowska","year":"2024","journal-title":"Antioxidants (Basel)"},{"issue":"7","key":"10.1016\/j.niox.2025.10.001_bib32","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/iub.1513","article-title":"Association of NOS2 and NOS3 gene polymorphisms with susceptibility to type 2 diabetes mellitus and diabetic nephropathy in the Chinese Han population","volume":"68","author":"Chen","year":"2016","journal-title":"IUBMB Life"},{"key":"10.1016\/j.niox.2025.10.001_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2024.112197","article-title":"Association between nitric oxide synthase (NOS3) gene polymorphisms and diabetic nephropathy: an updated meta-analysis","volume":"586","author":"Dobrijevi\u0107","year":"2024","journal-title":"Mol. Cell. Endocrinol."},{"issue":"12","key":"10.1016\/j.niox.2025.10.001_bib34","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.2337\/diacare.21.12.2195","article-title":"A common Glu298 Asp (894G T) mutation at exon 7 of the endothelial nitric oxide synthase gene and vascular complications in type 2 diabetes","volume":"21","author":"Cai","year":"1998","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.niox.2025.10.001_bib35","doi-asserted-by":"crossref","first-page":"500","DOI":"10.2337\/diabetes.49.3.500","article-title":"Association of the nitric oxide synthase gene polymorphism with an increased risk for progression to diabetic nephropathy in type 2 diabetes","volume":"49","author":"Neugebauer","year":"2000","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.niox.2025.10.001_bib36","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1159\/000065041","article-title":"T(-786)--C polymorphism of the endothelial nitric oxide synthase gene influences the progression of renal disease","volume":"91","author":"Asakimori","year":"2002","journal-title":"Nephron"},{"issue":"3","key":"10.1016\/j.niox.2025.10.001_bib37","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0168-8227(02)00156-0","article-title":"Endothelial nitric oxide synthase gene and the development of diabetic nephropathy","volume":"58","author":"Shimizu","year":"2002","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"2","key":"10.1016\/j.niox.2025.10.001_bib38","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1046\/j.1523-1755.2000.00860.x","article-title":"Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism","volume":"57","author":"Zanchi","year":"2000","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.niox.2025.10.001_bib39","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.diabres.2004.01.010","article-title":"Relations between eNOS Glu298Asp polymorphism and progression of diabetic nephropathy","volume":"65","author":"Shin Shin","year":"2004","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"7","key":"10.1016\/j.niox.2025.10.001_bib40","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1080\/07853890600969213","article-title":"Glu298Asp and NOS4ab polymorphisms in diabetic nephropathy","volume":"38","author":"M\u00f6llsten","year":"2006","journal-title":"Ann. Med."},{"issue":"5","key":"10.1016\/j.niox.2025.10.001_bib41","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jdiacomp.2007.11.011","article-title":"Association of endothelial nitric oxide synthase Glu298Asp, 4b\/a, and -786T>C gene variants with diabetic nephropathy","volume":"22","author":"Ezzidi","year":"2008","journal-title":"J. Diabetes Complicat."},{"issue":"1","key":"10.1016\/j.niox.2025.10.001_bib42","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ymgme.2009.01.013","article-title":"The endothelial nitric oxide synthase gene and risk of diabetic nephropathy and development of cardiovascular disease in type 1 diabetes","volume":"97","author":"M\u00f6llsten","year":"2009","journal-title":"Mol. Genet. Metabol."},{"issue":"4","key":"10.1016\/j.niox.2025.10.001_bib43","doi-asserted-by":"crossref","first-page":"560","DOI":"10.2337\/diacare.23.4.560","article-title":"CCTTT-repeat polymorphism in the human NOS2-promoter confers low risks of diabetic nephropathy in type 1 diabetic patients","volume":"23","author":"Johannesen","year":"2000","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.niox.2025.10.001_bib44","doi-asserted-by":"crossref","first-page":"878","DOI":"10.3109\/0886022X.2011.605978","article-title":"Impact of nitric oxide synthase Glu298Asp polymorphism on the development of end-stage renal disease in type 2 diabetic Egyptian patients","volume":"33","author":"El-Din","year":"2011","journal-title":"Ren. Fail."},{"issue":"2","key":"10.1016\/j.niox.2025.10.001_bib45","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.jgeb.2017.05.001","article-title":"Endothelial nitric oxide synthase gene (T786C and G894T) polymorphisms in Egyptian patients with type 2 diabetes","volume":"15","author":"Moguib","year":"2017","journal-title":"J. Genet. Eng. Biotechnol."},{"issue":"3","key":"10.1016\/j.niox.2025.10.001_bib46","doi-asserted-by":"crossref","first-page":"23","DOI":"10.14341\/DM2014323-30","article-title":"Risk of chronic kidney disease in type 2 diabetes determined by polymorphisms in NOS3, APOB, KCNJ11, TCF7L2 genes as compound effect of risk genotypes combination","volume":"17","author":"Zheleznyakova","year":"2014","journal-title":"Diabetes Mellitus"},{"issue":"1","key":"10.1016\/j.niox.2025.10.001_bib47","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11033-014-3736-y","article-title":"Association between genetic polymorphisms of ACE & eNOS and diabetic nephropathy","volume":"42","author":"Huo","year":"2015","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.niox.2025.10.001_bib48","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8736215","article-title":"CNDP1, NOS3, and MnSOD polymorphisms as risk factors for diabetic nephropathy among type 2 diabetic patients in Malaysia","volume":"2019","author":"Yahya","year":"2019","journal-title":"J. Nutr. Metab."},{"issue":"6","key":"10.1016\/j.niox.2025.10.001_bib49","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jdiacomp.2005.10.006","article-title":"Nitric oxide synthase gene polymorphisms and nephropathy in Asians with Type 2 diabetes","volume":"20","author":"Liao","year":"2006","journal-title":"J. Diabetes Complicat."},{"issue":"11","key":"10.1016\/j.niox.2025.10.001_bib50","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1111\/dme.14257","article-title":"Gene-environment interaction in chronic kidney disease among people with type 2 diabetes from the Malaysian Cohort project: a case-control study","volume":"37","author":"Ahmad","year":"2020","journal-title":"Diabet. Med."},{"issue":"1","key":"10.1016\/j.niox.2025.10.001_bib51","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s43042-022-00216-w","article-title":"Role of eNOS and TGF\u03b21 gene polymorphisms in the development of diabetic nephropathy in type 2 diabetic patients in South Indian population","volume":"23","author":"Varghese","year":"2022","journal-title":"Egyptian J. Med.l Human Genet."},{"issue":"1\u20132","key":"10.1016\/j.niox.2025.10.001_bib52","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11010-008-9759-8","article-title":"Endothelial nitric oxide synthase gene haplotypes and diabetic nephropathy among Asian Indians","volume":"314","author":"Ahluwalia","year":"2008","journal-title":"Mol. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.niox.2025.10.001_bib53","first-page":"219","article-title":"Endothelial nitric oxide synthase 4a\/B polymorphism and its interaction with enos G894T variants in type 2 diabetic patients: modifying the risk of diabetic nephropathy","volume":"51","author":"Mohammadi","year":"2022","journal-title":"Iran. J. Public Health"},{"issue":"5","key":"10.1016\/j.niox.2025.10.001_bib54","first-page":"11","article-title":"A case control study of risk assessment of diabetes and nephropathy with eNOS (T786C and 27bp VNTR) gene polymorphisms","volume":"70","author":"Anju","year":"2022","journal-title":"J. Assoc. Phys. India"},{"issue":"2","key":"10.1016\/j.niox.2025.10.001_bib55","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1681\/ASN.2006050459","article-title":"Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy","volume":"18","author":"Nakagawa","year":"2007","journal-title":"J. Am. Soc. Nephrol. : JASN"},{"issue":"2","key":"10.1016\/j.niox.2025.10.001_bib56","doi-asserted-by":"crossref","first-page":"619","DOI":"10.2353\/ajpath.2010.090578","article-title":"eNOS knockout mice with advanced diabetic nephropathy have less benefit from renin-angiotensin blockade than from aldosterone receptor antagonists","volume":"176","author":"Kosugi","year":"2010","journal-title":"Am. J. Pathol."},{"issue":"5","key":"10.1016\/j.niox.2025.10.001_bib57","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1073\/pnas.1018766108","article-title":"A modest decrease in endothelial NOS in mice comparable to that associated with human NOS3 variants exacerbates diabetic nephropathy","volume":"108","author":"Wang","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"2","key":"10.1016\/j.niox.2025.10.001_bib58","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.kint.2018.02.028","article-title":"Gene expression profiles of glomerular endothelial cells support their role in the glomerulopathy of diabetic mice","volume":"94","author":"Fu","year":"2018","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.niox.2025.10.001_bib59","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jdiacomp.2018.10.003","article-title":"Endothelial cell-specific overexpression of endothelial nitric oxide synthase in Ins2Akita mice exacerbates diabetic nephropathy","volume":"33","author":"Natarajan","year":"2019","journal-title":"J. Diabetes Complicat."},{"issue":"1","key":"10.1016\/j.niox.2025.10.001_bib60","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-79501-0","article-title":"Endothelial eNOS deficiency causes podocyte injury through NFAT2 and heparanase in diabetic mice","volume":"14","author":"Katagiri","year":"2024","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.niox.2025.10.001_bib61","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s004670200004","article-title":"Chronic diabetic nephropathy: role of inducible nitric oxide synthase","volume":"17","author":"Trachtman","year":"2002","journal-title":"Pediatric Nephrol. (Berlin, Germany)"},{"issue":"10","key":"10.1016\/j.niox.2025.10.001_bib62","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1681\/ASN.2006070798","article-title":"Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice","volume":"17","author":"Zhao","year":"2006","journal-title":"J. Am. Soc. Nephrol. : JASN"},{"issue":"5","key":"10.1016\/j.niox.2025.10.001_bib63","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/labinvest.2008.23","article-title":"Diabetic eNOS knockout mice develop distinct macro- and microvascular complications","volume":"88","author":"Mohan","year":"2008","journal-title":"Lab. Investig. J. Tech. Method. Pathol."},{"issue":"11","key":"10.1016\/j.niox.2025.10.001_bib64","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/ki.2012.248","article-title":"Improvement of endothelial nitric oxide synthase activity retards the progression of diabetic nephropathy in db\/db mice","volume":"82","author":"Cheng","year":"2012","journal-title":"Kidney Int."},{"issue":"12","key":"10.1016\/j.niox.2025.10.001_bib65","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1007\/s001250051088","article-title":"Increased expression of endothelial cell nitric oxide synthase (ecNOS) in afferent and glomerular endothelial cells is involved in glomerular hyperfiltration of diabetic nephropathy","volume":"41","author":"Sugimoto","year":"1998","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.niox.2025.10.001_bib66","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1046\/j.1463-1326.1999.00061.x","article-title":"Role of nitric oxide in renal function in rats with short and prolonged periods of streptozotocin\u2010induced diabetes","volume":"1","author":"Suanarunsawat","year":"1999","journal-title":"Diabetes Obes. Metabol."},{"issue":"1","key":"10.1016\/j.niox.2025.10.001_bib67","doi-asserted-by":"crossref","first-page":"p12","DOI":"10.1159\/000093276","article-title":"Chronic inhibition of nitric oxide production aggravates diabetic nephropathy in otsuka long-evans Tokushima fatty rats","volume":"104","author":"Kamijo","year":"2006","journal-title":"Nephron. Physiol."},{"issue":"2","key":"10.1016\/j.niox.2025.10.001_bib68","doi-asserted-by":"crossref","first-page":"F416","DOI":"10.1152\/ajprenal.00229.2009","article-title":"Nitric oxide originating from NOS1 controls oxygen utilization and electrolyte transport efficiency in the diabetic kidney","volume":"298","author":"Palm","year":"2010","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"3","key":"10.1016\/j.niox.2025.10.001_bib69","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1067\/mlc.2001.116843","article-title":"Inhibition of neuronal nitric oxide synthase ameliorates renal hyperfiltration in streptozotocin-induced diabetic rat","volume":"138","author":"Ito","year":"2001","journal-title":"J. Lab. Clin. Med."},{"issue":"2","key":"10.1016\/j.niox.2025.10.001_bib70","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1161\/01.HYP.35.2.655","article-title":"Effects of systemic inhibition of neuronal nitric oxide synthase in diabetic rats","volume":"35","author":"Komers","year":"2000","journal-title":"Hypertension (Dallas, Tex : 1979)"},{"issue":"1","key":"10.1016\/j.niox.2025.10.001_bib71","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1681\/ASN.V11171","article-title":"Nitric oxide synthase isoforms and glomerular hyperfiltration in early diabetic nephropathy","volume":"11","author":"Veelken","year":"2000","journal-title":"J. Am. Soc. Nephrol. : JASN"},{"issue":"10","key":"10.1016\/j.niox.2025.10.001_bib72","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.2337\/diab.43.10.1190","article-title":"Role of endothelium-derived nitric oxide in the pathogenesis of the renal hemodynamic changes of experimental diabetes","volume":"43","author":"Komers","year":"1994","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.niox.2025.10.001_bib73","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.3390\/ijms21062218","article-title":"Glucose and blood pressure-dependent pathways\u2013the progression of diabetic kidney disease","volume":"21","author":"Patel","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.niox.2025.10.001_bib74","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.3390\/ijms26073330","article-title":"Comprehending the role of metabolic and hemodynamic factors alongside different signaling pathways in the pathogenesis of diabetic nephropathy","volume":"26","author":"Ratan","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.niox.2025.10.001_bib75","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.tem.2005.02.003","article-title":"The renin\u2013angiotensin\u2013aldosterone system, glucose metabolism and diabetes","volume":"16","author":"Giacchetti","year":"2005","journal-title":"Trends Endocrinol. Metabol."},{"issue":"1","key":"10.1016\/j.niox.2025.10.001_bib76","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S1056-8727(00)00056-8","article-title":"Increased tubuloglomerular feedback reactivity is associated with increased NO production in the streptozotocin-diabetic rat","volume":"14","author":"Thorup","year":"2000","journal-title":"J. Diabetes Complicat."},{"issue":"12","key":"10.1016\/j.niox.2025.10.001_bib77","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/j.cellsig.2010.07.012","article-title":"Acute hyperglycemia rapidly stimulates VEGF mRNA translation in the kidney. Role of angiotensin type 2 receptor (AT2)","volume":"22","author":"Day","year":"2010","journal-title":"Cell. Signal."},{"issue":"9","key":"10.1016\/j.niox.2025.10.001_bib78","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074366","article-title":"H(2)S inhibits hyperglycemia-induced intrarenal renin-angiotensin system activation via attenuation of reactive oxygen species generation","volume":"8","author":"Xue","year":"2013","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.niox.2025.10.001_bib79","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1152\/physiolgenomics.00025.2017","article-title":"Enhanced hemodynamic responses to angiotensin II in diabetes are associated with increased expression and activity of AT1 receptors in the afferent arteriole","volume":"49","author":"Zhang","year":"2017","journal-title":"Physiol. Genom."},{"issue":"12","key":"10.1016\/j.niox.2025.10.001_bib80","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1097\/01.ASN.0000099374.58607.C9","article-title":"Increased renal vascular endothelial growth factor and angiopoietins by angiotensin II infusion is mediated by both AT1 and AT2 receptors","volume":"14","author":"Rizkalla","year":"2003","journal-title":"J. Am. Soc. Nephrol. : JASN"},{"issue":"4","key":"10.1016\/j.niox.2025.10.001_bib81","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1677\/JME-08-0112","article-title":"Role of angiotensin II-induced rapid response genes in the regulation of enzymes needed for aldosterone synthesis","volume":"42","author":"Nogueira","year":"2009","journal-title":"J. Mol. Endocrinol."},{"issue":"5","key":"10.1016\/j.niox.2025.10.001_bib82","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1111\/j.1476-5381.2011.01295.x","article-title":"Chronic treatment with angiotensin-(1-7) improves renal endothelial dysfunction in apolipoproteinE-deficient mice","volume":"163","author":"Stegbauer","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.niox.2025.10.001_bib83","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1161\/hy0302.104673","article-title":"Vasodilator action of angiotensin-(1-7) on isolated rabbit afferent arterioles","volume":"39","author":"Ren","year":"2002","journal-title":"Hypertension (Dallas, Tex : 1979)"},{"issue":"6","key":"10.1016\/j.niox.2025.10.001_bib84","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/ki.2011.381","article-title":"Angiotensin-converting enzyme 2: enhancing the degradation of angiotensin II as a potential therapy for diabetic nephropathy","volume":"81","author":"Batlle","year":"2012","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.niox.2025.10.001_bib85","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2337\/db06-0288","article-title":"Attenuation of angiotensin II signaling recouples eNOS and inhibits nonendothelial NOX activity in diabetic mice","volume":"56","author":"Oak","year":"2007","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.niox.2025.10.001_bib86","doi-asserted-by":"crossref","first-page":"R75","DOI":"10.1152\/ajpregu.00357.2011","article-title":"Acute and chronic effects of SGLT2 blockade on glomerular and tubular function in the early diabetic rat","volume":"302","author":"Thomson","year":"2012","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"6","key":"10.1016\/j.niox.2025.10.001_bib87","doi-asserted-by":"crossref","first-page":"R1840","DOI":"10.1152\/ajpregu.00457.2007","article-title":"Modulation of single-nephron GFR in the db\/db mouse model of type 2 diabetes mellitus. II. Effects of renal mass reduction","volume":"294","author":"Levine","year":"2008","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"10","key":"10.1016\/j.niox.2025.10.001_bib88","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.2337\/dc22-0921","article-title":"Activation of the tubulo-glomerular feedback by SGLT2 inhibitors in patients with type 2 diabetes and advanced chronic kidney disease: toward the end of a myth?","volume":"45","author":"G\u00e9rard","year":"2022","journal-title":"Diabetes Care"},{"issue":"17","key":"10.1016\/j.niox.2025.10.001_bib89","doi-asserted-by":"crossref","first-page":"9983","DOI":"10.1073\/pnas.171317998","article-title":"Mediation of tubuloglomerular feedback by adenosine: evidence from mice lacking adenosine 1 receptors","volume":"98","author":"Sun","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"1","key":"10.1016\/j.niox.2025.10.001_bib90","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1002\/j.2040-4603.2023.tb00248.x","article-title":"The role of macula densa nitric oxide synthase 1 beta splice variant in modulating tubuloglomerular feedback","volume":"13","author":"Liu","year":"2023","journal-title":"Compr. Physiol."},{"issue":"1","key":"10.1016\/j.niox.2025.10.001_bib91","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000499486","article-title":"Consequences of glomerular hyperfiltration: the role of physical forces in the pathogenesis of chronic kidney disease in diabetes and obesity","volume":"143","author":"Chagnac","year":"2019","journal-title":"Nephron"},{"issue":"8","key":"10.1016\/j.niox.2025.10.001_bib92","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/ndt\/gfae027","article-title":"Glomerular hyperfiltration as a therapeutic target for CKD","volume":"39","author":"Kanbay","year":"2024","journal-title":"Nephrol. Dial. Transplant."},{"issue":"1","key":"10.1016\/j.niox.2025.10.001_bib93","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3390\/biom12010143","article-title":"Antioxidant roles of SGLT2 inhibitors in the kidney","volume":"12","author":"Llorens-Cebri\u00e0","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.niox.2025.10.001_bib94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.diabres.2017.07.033","article-title":"Renal glucose metabolism in normal physiological conditions and in diabetes","volume":"133","author":"Alsahli","year":"2017","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"6","key":"10.1016\/j.niox.2025.10.001_bib95","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/01.mjt.0000178769.52610.69","article-title":"Advanced glycation end products and diabetic nephropathy","volume":"12","author":"Thomas","year":"2005","journal-title":"Am. J. Therapeut."},{"issue":"4","key":"10.1016\/j.niox.2025.10.001_bib96","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/S0002-9440(10)63909-0","article-title":"RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy","volume":"162","author":"Wendt","year":"2003","journal-title":"Am. J. Pathol."},{"issue":"8","key":"10.1016\/j.niox.2025.10.001_bib97","doi-asserted-by":"crossref","first-page":"952","DOI":"10.2174\/138945007781386884","article-title":"Molecular mechanisms of diabetic nephropathy and its therapeutic intervention","volume":"8","author":"Yamagishi","year":"2007","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.niox.2025.10.001_bib98","first-page":"1","article-title":"Effects of dietary advanced glycation end-products restriction on renal function in patients with diabetic nephropathy; a randomized, double-blind clinical trial","volume":"0","author":"Dashtabi","year":"2022","journal-title":"J. Ren. Inj. Prev."},{"key":"10.1016\/j.niox.2025.10.001_bib99","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1038\/sj.ki.5002386","article-title":"The role of protein kinase C activation in diabetic nephropathy","volume":"106","author":"Noh","year":"2007","journal-title":"Kidney Int. Suppl."},{"issue":"4","key":"10.1016\/j.niox.2025.10.001_bib100","doi-asserted-by":"crossref","first-page":"522","DOI":"10.2337\/diab.45.4.522","article-title":"Neutralization of TGF-Beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice","volume":"45","author":"Sharma","year":"1996","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.niox.2025.10.001_bib101","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1073\/pnas.90.5.1814","article-title":"Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy","volume":"90","author":"Yamamoto","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"3","key":"10.1016\/j.niox.2025.10.001_bib102","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1159\/000020527","article-title":"The renal TGF-beta system in the db\/db mouse model of diabetic nephropathy","volume":"6","author":"Cohen","year":"1998","journal-title":"Exp. Nephrol."},{"issue":"2","key":"10.1016\/j.niox.2025.10.001_bib103","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/ki.1996.65","article-title":"Expression of transforming growth factor-beta isoforms in human glomerular diseases","volume":"49","author":"Yamamoto","year":"1996","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.niox.2025.10.001_bib104","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1038\/ki.1996.162","article-title":"Quantification of glomerular TGF-beta 1 mRNA in patients with diabetes mellitus","volume":"49","author":"Iwano","year":"1996","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.niox.2025.10.001_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2019.107479","article-title":"Pro-inflammatory cytokines are associated with podocyte damage and proximal tubular dysfunction in the early stage of diabetic kidney disease in type 2 diabetes mellitus patients","volume":"34","author":"Milas","year":"2020","journal-title":"J. Diabetes Complicat."},{"issue":"3","key":"10.1016\/j.niox.2025.10.001_bib106","doi-asserted-by":"crossref","first-page":"F384","DOI":"10.1152\/ajprenal.00006.2004","article-title":"High concentration of glucose inhibits glomerular endothelial eNOS through a PKC mechanism","volume":"287","author":"Chu","year":"2004","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"11","key":"10.1016\/j.niox.2025.10.001_bib107","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.2337\/db06-0895","article-title":"Reduction of diabetes-induced oxidative stress, fibrotic cytokine expression, and renal dysfunction in protein kinase Cbeta-null mice","volume":"55","author":"Ohshiro","year":"2006","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.niox.2025.10.001_bib108","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.2337\/diacare.28.11.2686","article-title":"The effect of ruboxistaurin on nephropathy in type 2 diabetes","volume":"28","author":"Tuttle","year":"2005","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.niox.2025.10.001_bib109","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/ame2.12001","article-title":"Redox imbalance stress in diabetes mellitus: role of the polyol pathway","volume":"1","author":"Yan","year":"2018","journal-title":"Animal Mod. Exp. Med."},{"key":"10.1016\/j.niox.2025.10.001_bib110","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1046\/j.1523-1755.2000.07702.x","article-title":"Aldose reductase and the role of the polyol pathway in diabetic nephropathy","volume":"77","author":"Dunlop","year":"2000","journal-title":"Kidney Int. Suppl."},{"issue":"5","key":"10.1016\/j.niox.2025.10.001_bib111","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3390\/biom11050730","article-title":"NADH\/NAD(+) Redox imbalance and diabetic kidney disease","volume":"11","author":"Yan","year":"2021","journal-title":"Biomolecules"},{"issue":"40","key":"10.1016\/j.niox.2025.10.001_bib112","doi-asserted-by":"crossref","first-page":"28668","DOI":"10.1074\/jbc.M113.470971","volume":"288","author":"Lee","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.niox.2025.10.001_bib113","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3390\/antiox13040455","article-title":"Oxidative stress: a culprit in the progression of diabetic kidney disease","volume":"13","author":"Wang","year":"2024","journal-title":"Antioxidants"},{"issue":"3","key":"10.1016\/j.niox.2025.10.001_bib114","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3390\/jcm14030727","article-title":"Mechanisms, biomarkers, and treatment approaches for diabetic kidney disease: current insights and future perspectives","volume":"14","author":"Joumaa","year":"2025","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.niox.2025.10.001_bib115","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4093\/dmj.2020.0217","article-title":"Treatment of diabetic kidney disease: current and future","volume":"45","author":"Yamazaki","year":"2021","journal-title":"Diabete Metabol. J."},{"issue":"1","key":"10.1016\/j.niox.2025.10.001_bib116","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12882-025-03953-3","article-title":"New insights in the treatment of DKD: recent advances and future prospects","volume":"26","author":"Zhao","year":"2025","journal-title":"BMC Nephrol."},{"issue":"20","key":"10.1016\/j.niox.2025.10.001_bib117","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","article-title":"The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The collaborative study group","volume":"329","author":"Lewis","year":"1993","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.niox.2025.10.001_bib118","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.niox.2025.10.001_bib119","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1681\/ASN.2004110919","article-title":"Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial: clinical implications and limitations","volume":"16","author":"Pohl","year":"2005","journal-title":"J. Am. Soc. Nephrol. : JASN"},{"issue":"9","key":"10.1016\/j.niox.2025.10.001_bib120","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/j.clinthera.2015.05.508","article-title":"Spironolactone Add-on for preventing or slowing the progression of diabetic nephropathy: a meta-analysis","volume":"37","author":"Hou","year":"2015","journal-title":"Clin. Ther."},{"key":"10.1016\/j.niox.2025.10.001_bib121","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1264497","article-title":"Treatment and practical considerations of diabetic kidney disease","volume":"10","author":"Bilen","year":"2023","journal-title":"Front. Med."},{"issue":"6","key":"10.1016\/j.niox.2025.10.001_bib122","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.3390\/ijms25063086","article-title":"Recent advances in the management of diabetic kidney disease: slowing progression","volume":"25","author":"Wang","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.niox.2025.10.001_bib123","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1681\/ASN.V441039","article-title":"L-arginine administration prevents glomerular hyperfiltration and decreases proteinuria in diabetic rats","volume":"4","author":"Reyes","year":"1993","journal-title":"J. Am. Soc. Nephrol. : JASN"},{"issue":"11","key":"10.1016\/j.niox.2025.10.001_bib124","doi-asserted-by":"crossref","first-page":"F1292","DOI":"10.1152\/ajprenal.00176.2014","article-title":"Awad AS. Diabetic nephropathy is resistant to oral L-arginine or L-citrulline supplementation","volume":"307","author":"You","year":"2014","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"18","key":"10.1016\/j.niox.2025.10.001_bib125","article-title":"Awad AS. l-Homoarginine supplementation prevents diabetic kidney damage","volume":"7","author":"Wetzel","year":"2019","journal-title":"Phys. Rep."},{"issue":"5","key":"10.1016\/j.niox.2025.10.001_bib126","article-title":"Homoarginine ameliorates diabetic nephropathy independent of nitric oxide synthase-3","volume":"9","author":"Wetzel","year":"2021","journal-title":"Phys. Rep."},{"key":"10.1016\/j.niox.2025.10.001_bib127","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3389\/fimmu.2013.00480","article-title":"l-Citrulline protects from kidney damage in type 1 diabetic mice","volume":"4","author":"Romero","year":"2013","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.niox.2025.10.001_bib128","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.niox.2007.06.004","article-title":"Dietary nitrite inhibits early glomerular injury in streptozotocin-induced diabetic nephropathy in rats","volume":"17","author":"Ohtake","year":"2007","journal-title":"Nitric Oxide : Biol. Chem."},{"issue":"4","key":"10.1016\/j.niox.2025.10.001_bib129","first-page":"28","article-title":"Effect of four weeks of aerobic training with beetroot supplementation on some kidney damage biomarkers in elderly diabetic rats. Research","volume":"24","author":"Nejadrekabi","year":"2023","journal-title":"Sci. Magazine yafte."},{"key":"10.1016\/j.niox.2025.10.001_bib130","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/171546","article-title":"L-Arginine supplementation in type II diabetic rats preserves renal function and improves insulin sensitivity by altering the nitric oxide pathway","volume":"2014","author":"Claybaugh","year":"2014","journal-title":"Int J Endocrinol"},{"issue":"2","key":"10.1016\/j.niox.2025.10.001_bib131","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1161\/HYPERTENSIONAHA.114.03519","article-title":"L-Citrulline, but not L-arginine, prevents diabetes mellitus-induced glomerular hyperfiltration and proteinuria in rat","volume":"64","author":"Persson","year":"2014","journal-title":"Hypertension (Dallas, Tex : 1979)"},{"key":"10.1016\/j.niox.2025.10.001_bib132","article-title":"Sodium hydrosulfide has no additive effects on nitrite-inhibited renal gluconeogenesis in type 2 diabetic rats","author":"Jeddi","year":"2021","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.niox.2025.10.001_bib133","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3390\/medicina60030394","article-title":"Nephroprotective and anti-diabetic potential of beta vulgaris L. root (Beetroot) methanolic extract in a rat model of type 2 diabetes mellitus","volume":"60","author":"Al-Harbi","year":"2024","journal-title":"Medicina (Kaunas)"},{"issue":"3","key":"10.1016\/j.niox.2025.10.001_bib134","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3109\/2000-1967-147","article-title":"Transient glomerular hyperfiltration in the streptozotocin-diabetic Wistar Furth rat","volume":"106","author":"Palm","year":"2001","journal-title":"Upsala J. Med. Sci."},{"issue":"1","key":"10.1016\/j.niox.2025.10.001_bib135","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1186\/s12882-021-02530-8","article-title":"Non-invasive investigation of early kidney damage in streptozotocin-induced diabetic rats by intravoxel incoherent motion diffusion-weighted (IVIM) MRI","volume":"22","author":"Feng","year":"2021","journal-title":"BMC Nephrol."},{"issue":"23","key":"10.1016\/j.niox.2025.10.001_bib136","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3390\/ijms222312767","article-title":"L-NAME administration enhances diabetic kidney disease development in an STZ\/NAD rat model","volume":"22","author":"Corremans","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.niox.2025.10.001_bib137","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1159\/000449324","article-title":"Longitudinal changes in measured glomerular filtration rate, renal fibrosis and biomarkers in a rat model of type 2 diabetic nephropathy","volume":"44","author":"Su","year":"2016","journal-title":"Am. J. Nephrol."},{"issue":"Supplement_2","key":"10.1016\/j.niox.2025.10.001_bib138","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2337\/diab.32.2.S64","article-title":"The stages in diabetic renal disease: with emphasis on the stage of incipient diabetic nephropathy","volume":"32","author":"Mogensen","year":"1983","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.niox.2025.10.001_bib139","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.3390\/ijms22115425","article-title":"Kidney biopsy in type 2 diabetic patients: critical reflections on present indications and diagnostic alternatives","volume":"22","author":"Santoro","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.niox.2025.10.001_bib140","first-page":"75","article-title":"Diabetic kidney disease in elderly individuals","volume":"97","author":"Williams","year":"2013","journal-title":"Med. Clin."},{"issue":"4","key":"10.1016\/j.niox.2025.10.001_bib141","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1681\/ASN.2016060666","article-title":"Glomerular hyperfiltration in diabetes: mechanisms, clinical significance, and treatment","volume":"28","author":"Tonneijck","year":"2017","journal-title":"J. Am. Soc. Nephrol. : JASN"},{"issue":"5","key":"10.1016\/j.niox.2025.10.001_bib142","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1177\/1479164118776465","article-title":"Long-term prospective observation suggests that glomerular hyperfiltration is associated with rapid decline in renal filtration function: a multiethnic study","volume":"15","author":"Low","year":"2018","journal-title":"Diabetes Vasc. Dis. Res."},{"issue":"4","key":"10.1016\/j.niox.2025.10.001_bib143","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2020.107841","article-title":"Sex-related differences in diabetic kidney disease: a review on the mechanisms and potential therapeutic implications","volume":"35","author":"Piani","year":"2021","journal-title":"J. Diabetes Complicat."},{"issue":"1","key":"10.1016\/j.niox.2025.10.001_bib144","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s12020-016-1014-6","article-title":"Diabetes mellitus as a risk factor for incident chronic kidney disease and end-stage renal disease in women compared with men: a systematic review and meta-analysis","volume":"55","author":"Shen","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/j.niox.2025.10.001_bib145","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.freeradbiomed.2018.07.010","article-title":"Sex differences in the nitrate-nitrite-NO(\u2022) pathway: role of oral nitrate-reducing bacteria","volume":"126","author":"Kapil","year":"2018","journal-title":"Free Radic. Biol. Med."},{"issue":"4","key":"10.1016\/j.niox.2025.10.001_bib146","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1161\/01.HYP.32.4.730","article-title":"Evidence for a difference in nitric oxide biosynthesis between healthy women and men","volume":"32","author":"Forte","year":"1998","journal-title":"Hypertension (Dallas, Tex : 1979)"},{"issue":"1","key":"10.1016\/j.niox.2025.10.001_bib147","doi-asserted-by":"crossref","first-page":"H43","DOI":"10.1152\/ajpheart.00630.2004","article-title":"Sex differences in renal injury and nitric oxide production in renal wrap hypertension","volume":"288","author":"Ji","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"1 Pt 1","key":"10.1016\/j.niox.2025.10.001_bib148","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0895-7061(97)00360-9","article-title":"Gender differences in the renal nitric oxide (NO) system: dissociation between expression of endothelial NO synthase and renal hemodynamic response to NO synthase inhibition","volume":"11","author":"Reckelhoff","year":"1998","journal-title":"Am. J. Hypertens."},{"issue":"9","key":"10.1016\/j.niox.2025.10.001_bib149","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1681\/ASN.2005101095","article-title":"Gender differences in the renal response to renin-angiotensin system blockade","volume":"17","author":"Miller","year":"2006","journal-title":"J. Am. Soc. Nephrol. : JASN"},{"issue":"3","key":"10.1016\/j.niox.2025.10.001_bib150","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.neubiorev.2010.07.002","article-title":"Sex bias in neuroscience and biomedical research","volume":"35","author":"Beery","year":"2011","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"7500","key":"10.1016\/j.niox.2025.10.001_bib151","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/509282a","article-title":"Policy: NIH to balance sex in cell and animal studies","volume":"509","author":"Clayton","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.niox.2025.10.001_bib152","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122432","article-title":"Anti-obesity and anti-diabetic effects of L-citrulline are sex-dependent","volume":"339","author":"Bagheripour","year":"2024","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.niox.2025.10.001_bib153","doi-asserted-by":"crossref","DOI":"10.1111\/apha.13937","article-title":"Metabolic effects of L-citrulline in type 2 diabetes","volume":"237","author":"Bagheripour","year":"2023","journal-title":"Acta. Physiol. (Oxf)"},{"issue":"9","key":"10.1016\/j.niox.2025.10.001_bib154","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.2215\/CJN.01780213","article-title":"Mediterranean diet, kidney function, and mortality in men with CKD","volume":"8","author":"Huang","year":"2013","journal-title":"Clin. J. Am. Soc. Nephrol. : CJASN"},{"issue":"2","key":"10.1016\/j.niox.2025.10.001_bib155","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1053\/j.ajkd.2010.09.027","article-title":"Association of dietary patterns with albuminuria and kidney function decline in older white women: a subgroup analysis from the Nurses' Health Study","volume":"57","author":"Lin","year":"2011","journal-title":"Am. J. Kidney Dis. : off. J. National Kidney Found."},{"issue":"1","key":"10.1016\/j.niox.2025.10.001_bib156","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1681\/ASN.2020030384","article-title":"Modifiable lifestyle factors for primary prevention of CKD: a systematic review and meta-analysis","volume":"32","author":"Kelly","year":"2021","journal-title":"J. Am. Soc. Nephrol. : JASN"},{"issue":"1","key":"10.1016\/j.niox.2025.10.001_bib157","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MNH.0b013e32834d54ca","article-title":"Nitric oxide synthase derangements and hypertension in kidney disease","volume":"21","author":"Baylis","year":"2012","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.niox.2025.10.001_bib158","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.niox.2017.01.011","article-title":"Dietary nitrate load lowers blood pressure and renal resistive index in patients with chronic kidney disease: a pilot study","volume":"64","author":"Kemmner","year":"2017","journal-title":"Nitric Oxide : Biol. Chem."},{"issue":"12","key":"10.1016\/j.niox.2025.10.001_bib159","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3390\/nu8120811","article-title":"Association between dietary intakes of nitrate and nitrite and the risk of hypertension and chronic kidney disease: tehran lipid and glucose Study","volume":"8","author":"Bahadoran","year":"2016","journal-title":"Nutrients"},{"key":"10.1016\/j.niox.2025.10.001_bib160","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107781","article-title":"Inducible nitric oxide synthase (iNOS): more than an inducible enzyme? Rethinking the classification of NOS isoforms","volume":"216","author":"Farahani","year":"2025","journal-title":"Pharmacol. Res."}],"container-title":["Nitric Oxide"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089860325000825?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089860325000825?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T14:51:13Z","timestamp":1773154273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089860325000825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":160,"alternative-id":["S1089860325000825"],"URL":"https:\/\/doi.org\/10.1016\/j.niox.2025.10.001","relation":{},"ISSN":["1089-8603"],"issn-type":[{"value":"1089-8603","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetic nephropathy: Role of nitric oxide","name":"articletitle","label":"Article Title"},{"value":"Nitric Oxide","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.niox.2025.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}